English | Español

Biospace
+ Pharmaceuticals
Patient Daily | Feb 5, 2026

Novo Nordisk faces investor pressure despite strong obesity drug sales
+ Pharmaceuticals
Patient Daily | Feb 5, 2026

Biopharma employers show increased willingness toward hiring remote workers
+ Pharmaceuticals
Patient Daily | Feb 5, 2026

Regulatory professionals address challenges from new FDA guidance and evolving technology
+ Pharmaceuticals
Patient Daily | Feb 5, 2026

Merck ends talks with Revolution Medicines over acquisition price disagreement
+ Pharmaceuticals
Patient Daily | Feb 5, 2026

Sarepta reports sustained benefit from DMD gene therapy three years after treatment
+ Pharmaceuticals
Patient Daily | Feb 5, 2026

Corcept reports positive Phase III results for ovarian cancer drug relacorilant
+ Pharmaceuticals
Patient Daily | Feb 5, 2026

Sandbox approach proposed as new model for rare disease drug development
+ Pharmaceuticals
Patient Daily | Feb 5, 2026

Revolution Medicines remains independent after failed takeover talks with Merck

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation